| Protocol Number |
Title |
2002LS032
|
MT1999-06: Vaccination with Tetanus Toxoid and Keyhold Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses |
2002LS097
|
Twin Cities Brachytherapy Study for Ductal Carcinoma in Situ: A Phase II Trial |
2003NT030
|
Sentinel Lymph Node Biopsy before Preoperative Chemotherapy: Factors Associated with Non-Sentinel Lymph Node Metastases |
2005LS006
|
Breast MRI Assessment of Tumor Viability After Radiofrequency Ablation (RFA) |
2005LS068
|
Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies |
2006CG045
|
CTSU/ECOG PAACT-1: Program for the assessment of clinical cancer tests (PACCT-1) trial assigning individualized options for treatment: the TAILORx trial |
2006IS006
|
A prospective, randomized, double-blind, stratified, multi-center, 2-arm trial of the continued efficacy and safety of Zometa (every 4 weeks vs. every 12 weeks) in patients with documented bone metastases from breast cancer (Study No. CZOL446E2352) |
2006IS047
|
A Phase 1 Pharmacodynamic Study of CP-751,871 as Neoadjuvant Treatment for Early Breast Cancer |
2006LS016
|
Phase II Study of Naltrexone for the Treatment of Hormone-Refractory, Metastatic Breast Cancer |
2007IS025
|
A two-arm randomized open label phase 2 study of CP-751, 871 in combination with exemestane versus exemestane alone as a first line treatment for postmenopausal patients with hormone receptor positive advanced breast cancer (Pfizer A4021004) |
2007IS041
|
Phase II Study of the Trifunctional Bispecific Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab in Patients with HER-2/Neu Overexpressing (3+ by Dako Hercep Test? or FISH+) Metastatic Breast Cancer Progressing after Trastuzumab Treatment |
2007LS019
|
Phase I Clinical Trial of Trametes Versicolor in Women with Breast Cancer |
2007LS094
|
A Phase II Study of an Allogeneic Large Multivalent Immunogen (LMI) Vaccine for the Treatment of Stable, Metastatic Breast Cancer |
2007NT070
|
The Pharmacokinetics of a 41 Ca Marker for Bone Turnover in Breast Cancer Patients Treated with an Aromatase Inhibitor and Bisphosphonate. |
2007NT126
|
CALGB 150007: Contrast Enhanced Breast MRI and Correlative Science Studies to Characterize Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer- RUNS IN TANDEM WITH CALGB 150012, PLEASE SEE 2007NT140 FOR COMPLETE INFORMATION FOR BOTH PROTOCOLS. |
2007NT140
|
CALGB 150012: Contrast-Enhanced Breast MRI and MRS for Evaluation of Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer. (Must be Enrolled in CALGB 150007) |
2008IS091
|
A Randomized, Multicenter, Phase II Study of the Efficacy and Safety of Trastuzumab-MCC-DMI vs Trastuzumab (Herceptin?) and Docetaxel (Taxotere?) in Patients with Metastatic Her2-Positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease (TDM4450g) |
2008LS035
|
Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life |
2008NTLS060
|
The Effect of Enalapril on Doxorubicin Exposure in Adjuvant Breast Cancer Treatment |
2009NTLS077
|
Green Tea and Reduction of Breast Cancer Risk |
Clinical Trials Help